FXH ETF Analysis: Health Care AlphaDEX Fund | NYSE
Healthcare Equity | NYSE, USA | Market Cap: 1.154m USD | 12M Return: 26.4% | US33734X1431 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.83M
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The First Trust Health Care AlphaDEX® Fund (FXH) is an exchange-traded fund that invests at least 90% of its net assets in securities comprising its underlying index, a modified equal-dollar weighted benchmark that draws stocks from the Russell 1000® Index within the health care sector. The index applies the proprietary AlphaDEX® selection methodology, which uses quantitative factor screens to rank and select companies that may outperform traditional capitalization-weighted benchmarks. The health care sector tracked by the fund spans subsectors such as pharmaceuticals, biotechnology, medical devices, and health care services providers. As a modified equal-dollar weighted index, holdings are periodically rebalanced so that each constituent receives approximately equal dollar allocations rather than weights based on market capitalization.
- Healthcare sector rotation drives ETF inflows and outflows
- AlphaDEX methodology outperformance versus cap-weighted health benchmarks
- Drug pricing reform legislation pressures constituent pharma margins
As of November 11, 2026, the stock is trading at USD 139.06 with a total of 20,895 shares traded. Over the past week, the price has changed by +0.79%, over one month by +6.25%, over three months by +5.40% and over the past year by +26.40%.
Current recommended Stop Loss: 133.40 (which is 4.1% or 2.2 ATR below the current price).
Health Care AlphaDEX Fund has no consensus analysts rating.